● Recruiting

A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age

Condition: Excessive Daytime Sleepiness · Sponsor: Centessa Pharmaceuticals (UK) Limited

PhasePhase 1

Planned participants208

Who can joinAll sexes, 18 Years to 80 Years

Healthy volunteersYes

About this study

Characterize the safety, tolerability and pharmacokinetics of ORX142 following single and multiple doses.

This description comes directly from the study's public registry record.

Talk to the study team

ORX142 Centessa Program Lead · 617-468-5770 · ORX142-0101study@centessa.com

Always discuss trial participation with your own doctor first.

Locations (3)

Site #1	Lincoln, Nebraska, United States	Recruiting
Site #2	Eatontown, New Jersey, United States	Recruiting
Site #3	New York, New York, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07082829